CNV size portends subretinal hemorrhage after anti-VEGF therapy

Change of choroidal neovascularization size on indocyanine green angiography can predict recurrent exudation and/or subretinal hemorrhage after treat-and-extend therapy for neovascular age-related macular degeneration, according to a study.The retrospective study included 141 patients with neovascular age-related macular degeneration (AMD) who received bevacizumab (Avastin, Genentech) on a treat-and-extend basis for 12 months. Mean patient age was 77.3 years.